Express Scripts Holding Company Announces Third Quarter 2013 Earnings Conference Call

Express Scripts Holding Company Announces Third Quarter 2013 Earnings
Conference Call

ST. LOUIS, Oct. 10, 2013 (GLOBE NEWSWIRE) -- Express Scripts Holding Company
(Nasdaq:ESRX), the largest pharmacy benefit management company in North
America, announced today its intention to release its third quarter earnings
on Thursday, October 24, 2013 after the market closes and will hold its
quarterly conference call to discuss third quarter results on Friday, October
25, 2013, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

This call is being webcast and can be accessed at the Investor Information
section of Express Scripts' web site at
RealPlayer or Windows Media Player is needed to listen to the webcast and free
downloads of these players are available at the webcast site.

A slide presentation will be posted on our website. Following the conference
call, both the slide presentation and the webcast will remain available on the
Investor Information section of Express Scripts' website for 14 days.

About Express Scripts

Express Scripts (Nasdaq:ESRX) manages more than a billion prescriptions each
year for tens of millions of patients. On behalf of our clients – employers,
health plans, unions and government health programs – we make the use of
prescription drugs safer and more affordable. Express Scripts uniquely
combines three capabilities – behavioral sciences, clinical specialization and
actionable data – to create Health Decision Science^SM, our innovative
approach to help individuals make the best drug choices, pharmacy choices and
health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy
benefit management services, including network-pharmacy claims processing,
home delivery, specialty benefit management, benefit-design consultation,
drug-utilization review, formulary management, and medical and drug data
analysis services. The company also distributes a full range of
biopharmaceutical products and provides extensive cost-management and
patient-care services.

For more information, visit or follow @ExpressScripts
on Twitter.

CONTACT: Matt Harper, Interim Chief Financial Officer
         David Myers, Vice President Investor Relations
         (314) 810-3115
Press spacebar to pause and continue. Press esc to stop.